Patient Access Liaison - Texas
Intellia Therapeutics
About this role
The Patient Access Liaison (PAL) is a field-based role within Intellia’s patient access organization supporting commercialization of lonvo-z, an in vivo one-time CRISPR therapy. The PAL partners with providers, payers, and internal teams to facilitate patient access, coverage understanding, and site readiness across assigned accounts.
Skills
Qualifications
About Intellia Therapeutics
intelliatx.comIntellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Recent company news
Intellia TherapeuticsIntellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
1 week ago
Seeking AlphaIntellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory (NASDAQ:NTLA)
3 days ago
Yahoo FinanceIntellia Therapeutics, Inc. (NTLA): A Bull Case Theory
2 weeks ago
Intellia TherapeuticsIntellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
2 weeks ago
GlobeNewswireIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 days ago
About Intellia Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
Salary
$194k – $237k
per year